ACQUIREDT+30
Whitfield Roy A
Nektar Therapeutics · NASDAQ
+2,000 sh
Filed 25 Sept 2026SEC Form 4view source
Two Sigma Investments
13F filer
$67.0M
930,741 sh
Renaissance Technologies
13F filer
$3.0M
41,781 sh
Whitfield Roy A
US insider
—
2,000 sh
Brainard Diana
US insider
—
2,000 sh
Chess Robert
US insider
—
2,000 sh
Ajer Jeffrey Robert
US insider
—
2,000 sh
Greer R Scott
US insider
—
2,000 sh
Whitfield Roy A
Nektar Therapeutics · NASDAQ
+2,000 sh
Brainard Diana
Nektar Therapeutics · NASDAQ
+2,000 sh
Chess Robert
Nektar Therapeutics · NASDAQ
+2,000 sh
Ajer Jeffrey Robert
Nektar Therapeutics · NASDAQ
+2,000 sh
Greer R Scott
Nektar Therapeutics · NASDAQ
+2,000 sh
Robin Howard W
Nektar Therapeutics · NASDAQ
−418 sh · $30.1K
Zalevsky Jonathan
Nektar Therapeutics · NASDAQ
−186 sh · $13.4K
Renaissance Technologies
Nektar Therapeutics · NASDAQ
41,781 sh · $3.0M
Two Sigma Investments
Nektar Therapeutics · NASDAQ
930,741 sh · $67.0M